Varenicline Nasal Spray for the Treatment of Dry Eye Disease Following Corneal Collagen Crosslinking
Abstract Introduction To evaluate the safety and effectiveness of a varenicline solution nasal spray 0.03 mg (VNS) in reducing signs and symptoms of dry eye disease following corneal collagen cross-linking (CXL). Methods Subjects undergoing CXL were randomized to VNS (study) or vehicle (control) twi...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-03-01
|
| Series: | Ophthalmology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40123-025-01118-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|